Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXLANSOPRAZOLE Cause Joint injury? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Joint injury have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.1% of all adverse event reports for DEXLANSOPRAZOLE.

21
Reports of Joint injury with DEXLANSOPRAZOLE
0.1%
of all DEXLANSOPRAZOLE reports
18
Deaths
18
Hospitalizations

How Dangerous Is Joint injury From DEXLANSOPRAZOLE?

Of the 21 reports, 18 (85.7%) resulted in death, 18 (85.7%) required hospitalization, and 17 (81.0%) were considered life-threatening.

Is Joint injury Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does DEXLANSOPRAZOLE Cause?

Chronic kidney disease (15,973) Acute kidney injury (7,599) Renal failure (6,618) End stage renal disease (4,800) Renal injury (4,320) Tubulointerstitial nephritis (2,177) Death (1,417) Rebound acid hypersecretion (1,160) Gastrooesophageal reflux disease (1,013) Drug ineffective (859)

What Other Drugs Cause Joint injury?

ADALIMUMAB (1,966) ETANERCEPT (1,294) METHOTREXATE (1,091) TOFACITINIB (846) TOCILIZUMAB (712) ABATACEPT (660) PREDNISONE (621) HYDROXYCHLOROQUINE (609) INFLIXIMAB (603) RITUXIMAB (531)

Which DEXLANSOPRAZOLE Alternatives Have Lower Joint injury Risk?

DEXLANSOPRAZOLE vs DEXMEDETOMIDINE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXPANTHENOL DEXLANSOPRAZOLE vs DEXRAZOXANE

Related Pages

DEXLANSOPRAZOLE Full Profile All Joint injury Reports All Drugs Causing Joint injury DEXLANSOPRAZOLE Demographics